Description:
The successful candidate will join the Critical Reagents group to produce high quality critical reagent monoclonal and polyclonal antibodies to support the Biotherapeutics portfolio. Responsibilities include de novo antibody initiation, oversight of CROs, internal interface with stakeholders. Perform reagent modifications, characterization, and immunogen preparation. The candidate will be responsible exploring alternate methods for custom reagent generation. The incumbent will integrate informa
Apr 11, 2024;
from:
dice.com